Atypical Teratoid Rhabdoid Tumors (ATRT)
Oncology
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Atypical Teratoid Rhabdoid Tumors (ATRT)?
There are 1 clinical trial targeting Atypical Teratoid Rhabdoid Tumors (ATRT) tracked by BioSniper.
What is the prevalence of Atypical Teratoid Rhabdoid Tumors (ATRT)?
The estimated prevalence of Atypical Teratoid Rhabdoid Tumors (ATRT) is approximately 5.0 per 100,000 population.
Deep-dive into Atypical Teratoid Rhabdoid Tumors (ATRT)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis